Table 1.
Baseline characteristics of the study groups, PD and healthy controls. Mean ± SD or n (%).
| Parameter | PD, n = 27 | Healthy Controls, n = 44 |
|---|---|---|
| Age | 67.63 ± 8.15 | 64.36 ± 7.12 |
| Hoehn & Yahr score | 2.04 ± 0.71 | - |
| Montreal Cognitive Assessment scale | 21.8 ± 5.15 | - |
| Mini-Mental State Examination | 26.33 ± 1.52 | - |
| Duration of Parkinson’s disease | 7.32 ± 6.67 | - |
| Levodopa dosage | 554.35 ± 277.13 | - |
| Family history of Parkinson | 2 (7.69) | negative |
| Hypertension | 12 (46.15) | not diagnosed |
| Heart disease | 9 (34.62) | not diagnosed |
| Diabetes mellitus | 6 (23.08) | not diagnosed |
| Degeneration of the spine | 5 (19.23) | not diagnosed |